Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$1.87 -0.07 (-3.61%)
As of: Oct 21, 2026 · 10:06 AM EDT

Xtl Biopharmaceuticals (XTLB) Current Taxes (2009)

Updated

Xtl Biopharmaceuticals' Current Taxes came in at $3,000 for the quarter ended Dec 31, 2011.

Analysis

Xtl Biopharmaceuticals (XTLB) Current Taxes (2009) Analysis & Trends

  • Going back by year, Current Taxes was $72,000 in the year ended Dec 31, 2009.
  • The figure for the quarter ended Dec 31, 2011 represents the highest quarterly Current Taxes since the quarter ended Dec 31, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,134.06 Bn 1,102.65 Bn 19.71 Bn -
2 Johnson & Johnson 616.49 Bn 535.01 Bn 17.26 Bn 1.05 Bn
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn -
4 Merck 367.24 Bn 321.62 Bn 12.21 Bn 4.22 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 2.31 Bn
6 Astrazeneca 261.48 Bn 235.17 Bn 12.86 Bn 1.47 Bn
7 Amgen 236.17 Bn 191.57 Bn 7.24 Bn -
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn -
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn 653.00 Mn
10 Xtl Biopharmaceuticals 16.76 Mn 13.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 72,000.00
API Access

Xtl Biopharmaceuticals Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=XTLB&period=max&api_key=YOUR_API_KEY